Data also definately opens the door for a direct phase 2 study trial in PD based on page 12, as evidence of reduced iron in the globus pallidus.
Iron in the globus pallidus is a cause of parkinsons, than as mentioned by pivalde the significant reduction in brain atrophy likely increasing life expectancy...
Ann: Alterity Presents Encouraging New Phase 2 Data in MSA, page-43
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
-0.001(9.09%) |
Mkt cap ! $91.27M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.1¢ | 1.0¢ | $42.87K | 4.214M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 55000 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 6683005 | 16 |
View Market Depth
| Last trade - 15.48pm 23/06/2025 (20 minute delay) ? |
| ATH (ASX) Chart |